The Use of Tumor-Specific T Cells Reintroduced to Patients Requires

Multiple Choice

The use of tumor-specific T cells reintroduced to patients requires all of the following EXCEPT

A) tumor-specific cells being isolated.
B) tumor-specific cells being activated to overcome tumor-induced anergy.
C) the patient being lympho-depleted to facilitate reintroduction.
D) tumor-specific cells being depleted of autoreactive clones.
E) All of the answers are required steps.